Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Plos One
|
December 23, 2021
The risks and benefits of providing HIV services during the COVID-19 pandemic
John Stover, Sherrie L Kelly, Edinah Mudimu, et al.
Frontiers in Microbiology
|
June 12, 2018
CowPI: A Rumen Microbiome Focussed Version of the PICRUSt Functional Inference Software
Toby J Wilkinson, Sharon A Huws, Joan E Edwards, et al.
Malaria Journal
|
September 14, 2017
Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations
Nick Scott, S Azfar Hussain, Rowan Martin-Hughes, et al.
AIDS (London, England)
|
January 22, 2019
Applying the 'no-one worse off' criterion to design Pareto efficient HIV responses in Sudan and Togo
Robyn M Stuart, Hassan Haghparast-Bidgoli, Jasmina Panovska-Griffiths, et al.
Plos One
|
May 26, 2022
Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study
Debra C Ten Brink, Rowan Martin-Hughes, Mark E Minnery, et al.
BMC Public Health
|
October 27, 2023
A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study
Haroon Moolla, Andrew Phillips, Debra Ten Brink, et al.
The Lancet. HIV
|
September 8, 2024
Optimising HIV spending in 12 eastern European and central Asian countries: a modelling study
Debra C Ten Brink, Anna L Bowring, Rowan Martin-Hughes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 5, 2024
New HIV Infections Among Key Populations and Their Partners in 2010 and 2022, by World Region: A Multisources Estimation
Eline L Korenromp, Keith Sabin, John Stover, et al.
Journal of Clinical Microbiology
|
March 4, 2011
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay
Philippe M Hauser, Jacques Bille, Cornelia Lass-Flörl, et al.
The Lancet. Global Health
|
August 12, 2022
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models
Anna Bershteyn, Lise Jamieson, Hae-Young Kim, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Plos One
|
December 23, 2021
The risks and benefits of providing HIV services during the COVID-19 pandemic
John Stover, Sherrie L Kelly, Edinah Mudimu, et al.
Frontiers in Microbiology
|
June 12, 2018
CowPI: A Rumen Microbiome Focussed Version of the PICRUSt Functional Inference Software
Toby J Wilkinson, Sharon A Huws, Joan E Edwards, et al.
Malaria Journal
|
September 14, 2017
Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations
Nick Scott, S Azfar Hussain, Rowan Martin-Hughes, et al.
AIDS (London, England)
|
January 22, 2019
Applying the 'no-one worse off' criterion to design Pareto efficient HIV responses in Sudan and Togo
Robyn M Stuart, Hassan Haghparast-Bidgoli, Jasmina Panovska-Griffiths, et al.
Plos One
|
May 26, 2022
Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study
Debra C Ten Brink, Rowan Martin-Hughes, Mark E Minnery, et al.
BMC Public Health
|
October 27, 2023
A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study
Haroon Moolla, Andrew Phillips, Debra Ten Brink, et al.
The Lancet. HIV
|
September 8, 2024
Optimising HIV spending in 12 eastern European and central Asian countries: a modelling study
Debra C Ten Brink, Anna L Bowring, Rowan Martin-Hughes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 5, 2024
New HIV Infections Among Key Populations and Their Partners in 2010 and 2022, by World Region: A Multisources Estimation
Eline L Korenromp, Keith Sabin, John Stover, et al.
Journal of Clinical Microbiology
|
March 4, 2011
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay
Philippe M Hauser, Jacques Bille, Cornelia Lass-Flörl, et al.
The Lancet. Global Health
|
August 12, 2022
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models
Anna Bershteyn, Lise Jamieson, Hae-Young Kim, et al.
Page
of 5